References
- Anonymous. Dextropropoxyphene [Internet]. European Medicines Agency. 2018. [cited 2021 Oct 4]. Available from: https://www.ema.europa.eu/en/medicines/human/referrals/dextropropoxyphene
- Research C for DE and FDA Drug Safety Communication: FDA recommends against the continued use of propoxyphene. FDA [Internet]. 2019. [cited 2021 Oct 4]; Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-against-continued-use-propoxyphene
- Research C for DE and FDA Drug Safety Communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. FDA [Internet]. 2021. [cited 2021 Oct 4]; Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and
- European Medicines Agency. PRAC recommends restricting the use of codeine when used for pain relief in children. Available from: https://www.ema.europa.eu/en/news/prac-recommends-restricting-use-codeine-when-used-pain-relief-children.
- Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual report of the American association of poison control Centers’ National Poison Data System (NPDS): 37th annual report. Clin Toxicol. 2020;58(12):1360–1541.
- Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997;35(4):361–364.
- Tsutaoka BT, Ho RY, Fung SM, et al. Comparative toxicity of tapentadol and tramadol utilizing data reported to the national poison data system. Ann Pharmacother. 2015;49(12):1311–1316.
- Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 2005;39(6):1039–1044.
- Hassanian-Moghaddam H, Farajidana H, Sarjami S, et al. Tramadol-induced apnea. Am J Emerg Med. 2013;31(1):26–31.
- Nakhaee S, Amirabadizadeh A, Brent J, et al. Tramadol and the occurrence of seizures: a systematic review and meta-analysis. Crit Rev Toxicol. 2019;49(8):710–723.
- Murray BP, Carpenter JE, Dunkley CA, et al. Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clin Toxicol. 2019;57(8):692–696.
- Bianconi G, Malissin I, Labat L, et al. Marked and prolonged serotonin toxicity in a tramadol-poisoned patient with a pharmacokinetic study. Clin Toxicol. 2021;1–4. DOI: https://doi.org/10.1080/15563650.2021.1955912
- Prakash S, Rathore C, Rana K, et al. Fatal serotonin syndrome: a systematic review of 56 cases in the literature. Clin Toxicol. 2021;59(2):89–100.
- Nakhaee S, Hoyte C, Dart RC, et al. A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forensic Toxicol. 2021;39(2):293–310.
- Stassinos GL, Gonzales L, Klein-Schwartz W. Characterizing the toxicity and dose-effect profile of tramadol ingestions in children. Pediatr Emerg Care. 2019;35(2):117–120.
- Hassanian-Moghaddam H, Farnaghi F, Rahimi M. Tramadol overdose and apnea in hospitalized children, a review of 20 cases. Res Pharm Sci. 2015;10(6):544–552.
- Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923.
- Open Medic: base complète sur les dépenses de médicaments interrégimes – data.gouv.fr [Internet]. [cited 2021 Oct 18]. Available from: https://www.data.gouv.fr/fr/datasets/open-medic-base-complete-sur-les-depenses-de-medicaments-interregimes/
- Le Roux G, Sinno-Tellier S, Puskarczyk E, et al. Poisoning during the COVID-19 outbreak and lockdown: retrospective analysis of exposures reported to French poison control centres. Clin Toxicol. 2021;59:832–839.
- Ardakani YH, Rouini M-R. Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers. Biopharm Drug Dispos. 2007;28(9):527–534.
- Persson HE, Sjöberg GK, Haines JA, et al. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol. 1998;36(3):205–213.
- Luscombe MD, Owens BD, Burke D. Weight estimation in paediatrics: a comparison of the APLS formula and the formula ‘Weight = 3(age)+7’. Emerg Med J. 2011;28(7):590–593.
- Chiew AL, Buckley NA. The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes. Clin Toxicol. 2021;60:143–158.
- Iravani FS, Akhgari M, Jokar F, et al. Current trends in tramadol-related fatalities, Tehran, Iran 2005–2008. Subst Use Misuse. 2010;45(13):2162–2171.
- Morley SR, Becker J, Al-Adnani M, et al. Drug- and alcohol-related deaths at a pediatric institution in the United Kingdom. Am J Forensic Med Pathol. 2012;33(4):390–394.
- Vodovar D, Mégarbane B. Seizures induced by tramadol overdose: what is the respective contribution of tramadol and each of its metabolites? Drug Metab Pers Ther. 2019;34(1):20180025.
- Gaedigk A, Sangkuhl K, Whirl-Carrillo M, et al. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017;19(1):69–76.
- Lagard C, Chevillard L, Malissin I, et al. Mechanisms of tramadol-related neurotoxicity in the rat: does diazepam/tramadol combination play a worsening role in overdose? Toxicol Appl Pharmacol. 2016;310:108–119.
- Chyka PA, Seger D, Krenzelok EP, et al. Position paper: single-dose activated charcoal. Clin Toxicol. 2005;43:61–87.
- Hoegberg LCG, Shepherd G, Wood DM, et al. Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose. Clin Toxicol. 2021;59:1196–1227.
- Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146–155.
- Lagard C, Malissin I, Indja W, et al. Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat. Clin Toxicol. 2018;56(8):737–743.
- Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol. 2007;45(8):943–945.
- Dufayet L, Monnet F, Laborde-Casterot H, et al. Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French poison control center study. Clin Toxicol. 2021;59(5):433–439.
- Verdu E, Blanc-Brisset I, Meyer G, et al. Second-generation antihistamines: a study of poisoning in children. Clin Toxicol. 2020;58(4):275–283.